Walter Moos

Current

• Vice President at SRI International

Past

• Chairman & CEO at MitoKor
• Vice President at Chiron Corporation
• Vice President at Warner-Lambert/Parke-Davis

see less...

Education

• Harvard University
• University of California, Berkeley

Connections

63 connections

Industry

Biotechnology

Websites

• My Company

Walter Moos’s Experience

• Vice President

  SRI International

  (Non-Profit; 1001-5000 employees; Research industry)

  March 2005 — Present (3 years 10 months)

  Biosciences Division
  Basic Research like a University
  Drug Discovery like a Biotech Company
  Preclinical Development Services like a CRO
  Menlo Park, CA

• Chairman & CEO

  MitoKor

  (Privately Held; MGI; Biotechnology industry)

  January 1997 — August 2004 (7 years 8 months)

  Pioneering Mitochondrial Medicine
  Drug Discovery and Development
  MitoKor Merged with Micrologix in 2004
  New Company Renamed Migenix (TSX:MGI)
  San Diego, CA, and Vancouver, BC

• Vice President

  Chiron Corporation

  (Public Company; 5001-10,000 employees; NVS; Biotechnology industry)

  October 1991 — January 1997 (5 years 4 months)

  CHIR Acquired by Novartis in 2006
  Emeryville, CA

• Vice President

  Warner-Lambert/Parke-Davis

  (Public Company; 10,001 or more employees; PFE; Pharmaceuticals industry)

  March 1982 — October 1991 (9 years 8 months)

  WLA Acquired by Pfizer in 2000
  Ann Arbor, MI

Walter Moos’s Education

• Harvard University

  A.B., Chemistry

• University of California, Berkeley

  Ph.D., Chemistry

Additional Information

Walter Moos’s Websites:

• My Company

Walter Moos’s Interests:

Publications and Patents: 140 Advisory Boards and Committees: served on academic, editorial, government, industry, and venture capital groups Interests: pharmaceutical research and development, drug discovery, biotechnology business and science strategy and general management, medicinal, bio-organic, and combinatorial chemistry, mitochondrial biology, estrogens and hormone replacement therapy, neurodegenerative diseases including Alzheimer’s

Walter Moos’s Groups:

Past and Present Boards of Directors:
Nonprofit - BIO, Critical Path Institute, Keystone Symposia
Public - Migenix (TSX:MGI), Onyx (NASDAQ:ONXX), Rigel (NASDAQ:RIGL)
Private - Alnis, Anterion, Axiom, CMPS, Mimotopes, Oncologic

Past and Present Adjunct Professorships:
James Madison University
University of California, San Francisco (UCSF)
University of Michigan

Walter Moos’s Contact Settings

Interested In:

• expertise requests
• business deals
• reference requests
• getting back in touch